Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Annals of Surgical Oncology|November 12, 2005
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II studyAjay V Maker, Giao Q Phan, Peter Attia, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigensGiao Q Phan, Christopher E Touloukian, James C Yang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2011
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapySteven A Rosenberg, James C Yang, Richard M Sherry, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2025
Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 StudyTheresa Medina, Jason A Chesney, Harriet M Kluger, et al.Journal of the American College of Surgeons|August 31, 2010
Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal diseaseAarti Mathur, Clinton D Kemp, Utpal Dutta, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2005
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4Peter Attia, Giao Q Phan, Ajay V Maker, et al.Annals of Surgical Oncology|December 13, 2012
A novel nomogram for peritoneal mesothelioma predicts survivalNicholas P Schaub, Meghna Alimchandani, Martha Quezado, et al.Blood|December 14, 2011
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cellsJames N Kochenderfer, Mark E Dudley, Steven A Feldman, et al.Proceedings of the National Academy of Sciences of the United States of America|June 27, 2003
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanomaGiao Q Phan, James C Yang, Richard M Sherry, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2015
Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanomaLing Zhang, Richard A Morgan, Joal D Beane, et al.Pageof 4